Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

597 SNPs for the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Definitions of traits for association analyses. by Dai Nogimura (21445649)

Subjects:

Age and sex distribution of the participants. by Dai Nogimura (21445649)

Subjects:

Complete results of regression analyses of the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

eQTL analysis for proxy SNPs of <i>PRMT6</i>-<i>NTNG1</i> rs12028323. by Dai Nogimura (21445649)

Subjects:

Decreased expression of <i>catp-3</i> underlies compromised tolerance to oxidative stress in <i>shk-1</i> mutants. by Longjun Pu (20685717)

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. by Kevin J. Johnson (2647639)

Summary of subgroup analysis results. by Junyin Pan (20700411)

Subjects:

Original study data. by Junyin Pan (20700411)

Subjects:

S2 File - by Junyin Pan (20700411)

Subjects:

Table 1_Prognostic significance of fibrinogen levels in sepsis-associated acute kidney injury: unveiling a nonlinear relationship and clinical implications.docx by Manqin Chen (20129541)

“…Nevertheless, its significance as a prognostic marker for sepsis-associated acute kidney injury (SA-AKI) remains uncertain. …”

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)

Forest plot. by Junyin Pan (20700411)

Subjects:

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... by Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the neurotransmitters levels, acetylcholine (I) and dopamine (II). by Amoura M. Abou-El-Naga (21001524)

S1A Fig raw image. by Rachel K. Meade (22216529)

“…<i><i>Ctsz</i></i> disturbance within murine macrophages enhances production of chemokine (C-X-C motif) ligand 1 (CXCL1), a known biomarker of TB severity. From a Ugandan household contact study, we identify significant associations between <i>CTSZ</i> variants and TB disease severity. …”

Funnel plot. by Junyin Pan (20700411)

Subjects:

Tcj2 mRNA LNPs elicited humoral and cellular immune responses in a mouse immunogenicity study. by Leroy Versteeg (4248760)